knowledge -WSS

knowledge

author：fashion 2025-09-02 22:07:28 - browse：5

Researchers say they’ve been able to measure recovery from treatment-resistant depression through brain scans — a crucial step toward quantifying the impact of therapies on a condition whose progress is notoriously difficult to measure objectively. And that’s thanks to generative AI, they say.

In a small study published Wednesday — just 10 people with severe, treatment-resistant depression receiving deep brain stimulation therapy — researchers used the electrodes to record brain activity and later fed the scans into a homegrown artificial intelligence system that analyzed them for patterns. They found that it was possible to track patients’ recovery through changes in brain cells’ electrical activity.

Finding so-called biomarkers, or objective measurements reflecting depression, could help diagnose depression, track its progression, predict a relapse, and better tailor therapies to individual patients. But finding those metrics has been difficult, partly because depression’s biological impact isn’t well understood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Traditional Chinese medicine benefits explored in new JAMA study

WSS

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Alkermes shareholders re

The high cost of giving birth even with insurance

The high cost of giving birth even with insurance

Senate panel to vote on hospitals, PBMs, prisoner care

Apple is now the first public company to be valued at $3 trillion

Wikipedia

knowledge

explore

Moonlake's readout produced a cash windfall. Risks remain

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Continuity nursing helped my family in our darkest PICU moments

23andMe had bad news about my health. I wish a person had delivered it

The high cost of giving birth even with insurance

Peter Hotez and the public health issue of online harassment

George Santos makes 1st court appearance after pleading not guilty to 13 counts

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Continuity nursing helped my family in our darkest PICU moments

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

focus

In Memoriam: Notable people who died in 2023

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

United colonoscopy coverage change 'may cost lives,' doctors say

Medical leaders decry Supreme Court decision on affirmative action

knowledge

entertainment

entertainment

hotspot